-- Intact Financial(IFC.TO)週二表示,其第一季利潤成長。 淨利年增11%,達7.52億美元,合每股4.12美元,去年同期為6.76億美元,合每股3.69美元。 營業直接保費收入(DPW)成長4%,達到56億美元。該公司表示,成長主要得益於商業險和特殊險種業務的成長,尤其是在英國和愛爾蘭,以及個人險種業務的持續強勁成長。 承保收入(衡量已收保費與已付賠款及費用之間的差額)在本季度也增長了4%,達到5.04億美元。 綜合營運比率與去年同期持平,為91.3%。 Intact將於6月30日向6月16日登記在冊的股東派發每股1.47美元的季度股利。 「我們專注於透過商業和特種產品線的定價策略、產品線擴張和分銷舉措來推動獲利成長,這項策略正在取得成效,」執行長查爾斯·布林達莫爾表示。 「我們強勁的資產負債表和資本產生能力使我們能夠保持充足的資金來尋求收購機會。這也使我們能夠在股價被嚴重低估時進行股票回購。我們將繼續朝著財務目標邁進,即每年實現比行業平均水平高出500個基點的淨資產收益率(ROE)和每年10%的淨營業利潤(NOIPS)增長。」 Infact Financial的股票在多倫多證券交易所收盤上漲1.02美元,至259.10美元。
Related Articles
Simcere Pharmaceutical Receives Chinese Regulatory Approval to Begin Trials of Tumor Drug
Simcere Pharmaceutical (HKG:2096) received Chinese regulatory approval to begin clinical trials of SIM0613, according to a Hong Kong bourse filing Wednesday.The injection is intended to treat advanced solid tumors and is licensed to Ipsen Pharma in regions outside Greater China.
Meitu Records 30% Rise in Paying Subscribers
Meitu (HKG:1357) said the number of paying subscribers using its platform grew 30% year on year to 17.90 million as of end March, according to a Hong Kong bourse filing Wednesday.Paying subscribers for the company's productivity tools grew 53% to 2.34 million, while leisure app subscribers increased 27% to 15.56 million, the firm said.The company's core revenue grew 34.3% year on year to 852 million yuan, while other businesses remained "stable overall."The company's annual recurring revenue for AI-driven productivity apps stood at 580 million yuan as of March, a 56% increase from a year earlier.
Yidu Tech Unit Wins SG$2.3 Million Singapore Healthcare Project
Yidu Tech (HKG:2158) said its subsidiary EVYD Research Private Limited won a contract from Singapore Health Services for the implementation and support of Dr Buddy, according to a Wednesday Hong Kong bourse filing.The total project amount is about SG$2.3 million.